National Cancer Institute, Research Contracts Branch, ESS, Executive Plaza South, Rm. 620, 6120 Executive Blvd., MSC 7224, Bethesda, MD 20892-7224

A -- HPV TYPE 16 VACCINE TRIAL IN COSTA RICA SOL N01-CP-11005-50 DUE 110600 POC Karen L. McFarlane, Contracting Officer, (301) 435-3782 E-MAIL: Karen L. McFarlane, km63k@nih.gov. The Environmental Epidemiology Branch (EEB) of the Division of Cancer Epidemiology and Genetics (DCEG) of the National Cancer Institute (NCI) intends to negotiate with FUCODOCSA, Costa Rican Bureau of Social Security, Costa Rica, for a eight year contract for the conduct of a randomized clinical trial of 20,000 women 18-25 years to evaluate the efficacy of human papillomavirus vaccines. Authority: 41 USC 253(c)(1), as set forth in FAR 6.302-1. See numbered Note 22. Numbered Note 22 applies as follows: The proposed contract action is for supplies or services for which the Governrment intends to solicit and negotiate with only one source under the authority of FAR 6.302. Interested persons may identify their interest and capability to respond to the requirement or submit proposals. This notice of intent is not a request for competitive proposals. However, all proposals received within 45 days (30 days if award is issued under an existing basic ordering agreement) after date of publication of this synopsis will be considered by the Government. A determination by the Government not to compete with this proposed contract based upon responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement. No collect calls will be accepted. Posted 07/31/00 (W-SN480308). (0213)

Loren Data Corp. http://www.ld.com (SYN# 0001 20000802\A-0001.SOL)

| A - Research and Development Index  |  Issue Index |